Hear AtLast Holdings, Inc. (HRAL)
USD 0.0
(-10.0%)
USD 0.0
(-10.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | - USD | -100.0% |
| 2021 | 1149.00 USD | -99.66% |
| 2020 | 338.54 Thousand USD | -0.72% |
| 2019 | 341 Thousand USD | 340900.0% |
| 2018 | 100.00 USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2021 Q1 | 352.26 Thousand USD | 4.05% |
| 2021 FY | 1149.00 USD | -99.66% |
| 2021 Q2 | 352.04 Thousand USD | -0.06% |
| 2021 Q4 | 1149.00 USD | -99.66% |
| 2021 Q3 | 340.86 Thousand USD | -3.18% |
| 2020 Q4 | 338.54 Thousand USD | 0.48% |
| 2020 Q3 | 336.93 Thousand USD | 0.21% |
| 2020 FY | 338.54 Thousand USD | -0.72% |
| 2020 Q1 | 341.91 Thousand USD | 0.27% |
| 2020 Q2 | 336.22 Thousand USD | -1.67% |
| 2019 Q1 | 100.00 USD | 0.0% |
| 2019 Q4 | 341 Thousand USD | -6.02% |
| 2019 Q3 | 362.85 Thousand USD | 6.85% |
| 2019 Q2 | 339.6 Thousand USD | 339500.0% |
| 2019 FY | 341 Thousand USD | 340900.0% |
| 2018 Q2 | 100.00 USD | 0.0% |
| 2018 FY | 100.00 USD | 0.0% |
| 2018 Q4 | 100.00 USD | 0.0% |
| 2018 Q3 | 100.00 USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 100.0% |
| Ansell Limited | 3.23 Billion USD | 100.0% |
| Ansell Limited | 3.24 Billion USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 488.98 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 300.36 Thousand USD | 100.0% |
| Psykey, Inc. | 1.72 Million USD | 100.0% |
| ConvaTec Group Plc | 3.7 Billion USD | 100.0% |
| ConvaTec Group Plc | 3.71 Billion USD | 100.0% |
| Encision Inc. | 3.81 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Innovative MedTech Inc. | 651.88 Thousand USD | 100.0% |
| LifePoint, Inc. | 8.8 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 5.48 Million USD | 100.0% |
| Reflect Scientific, Inc. | 2.66 Million USD | 100.0% |
| SmileDirectClub, Inc. | 597.06 Million USD | 100.0% |
| Sector 10, Inc. | 1000.00 USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 100.0% |
| SheerVision, Inc. | 837.56 Thousand USD | 100.0% |
| United Health Products, Inc. | 284.64 Thousand USD | 100.0% |
| Vasamed, Inc. | 1.6 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 2.34 Million USD | 100.0% |